1. Statins in France:
Facts about drug consumption
Guy-André Pelouze MD, MSc

2. CHD and stroke in France

5. Statin consumption and cost

6. FAQ
1. How a country where CHD & Stroke are the
less prevalent in EOCD could consumpt so
much statins?
2. Is it efficient?
3. If so what are the difference between sex,
ethnic groups and geographic locations?
4. What is the cost of one life saved in a low
prevalence of disease
5. Is this consumption crowding out statin
prescription and use in symptomatic patients?
6. What is the cost of statins side effects in this
population?

7. Answer(s)
1. At the present time no study of the french
population can answer these questions
2. There is no open data available from the
french single third payer on the subject

8. Can we compute CHD rates previous
and after statin era?

9. Evolution of CHD rates before and after statin therapy (OECD)

10. Results of statins in France:
Cardiovascular heaven or illusion?
1. French people consume a lot of saturated
fats
2. they have a rather low rate of obesity even if
the increase is significant in the recent
decennals (3%, 6%, 9%)
3. Is the present very low prevalence of CV
diseases in France the result of long term
hypolipemic drug consumption?
4. Is it on the contrary the result of other factors
badly identified as the french paradox?

11. Thank you for your attention